MedTrace Logo

Comparative Evaluation of Ambu AuraGain Laryngeal Mask and Proseal Laryngeal Mask Airway

NCT03139292 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2019-12-30

No results posted yet for this study

Summary

Comparison of two different supraglottic airway devices i.e., the ProSeal Laryngeal Mask Airway (PLMA) and Ambu AuraGain, a third generation laryngeal mask Airway.

Conditions

  • Laryngeal Masks

Interventions

DEVICE

ProSeal Laryngeal Mask Airway

ProSeal Laryngeal Mask Airway was used as the supraglottic device

DEVICE

AmbuAuraGain Laryngeal Mask Airway

AmbuAuraGain Laryngeal Mask Airway was used as the supraglottic device

Sponsors & Collaborators

  • Tata Main Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-10-31
Completion
2019-10-31

Countries

  • India

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03139292 on ClinicalTrials.gov